ImmunityBio, Inc. IBRX Warrants And Rights Outstanding
Warrants And Rights Outstanding at other companies
Other financials
Where this comes from
Reported directly by ImmunityBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:WarrantsAndRightsOutstanding.
The official record: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about ImmunityBio, Inc.'s warrants and rights outstanding.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ImmunityBio, Inc.'s warrants and rights outstanding?
- ImmunityBio, Inc. (IBRX) reported warrants and rights outstanding of $308.19M in Q1 2026.
- How has ImmunityBio, Inc.'s warrants and rights outstanding changed year-over-year?
- ImmunityBio, Inc.'s warrants and rights outstanding increased by 3315.6% year-over-year, from $9.02M to $308.19M.
- What does warrants and rights outstanding mean?
- This represents the financial value or count of warrants and rights issued by the company that allow holders to purchase equity at a specified price. These instruments represent potential future dilution for existing shareholders. Monitoring these is important for understanding the company's fully diluted share count and capital structure.